Alzamend Neuro, Inc. (ALZN): EPS (Diluted)
-$2.63
Year ended 2026-04-30
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2026-04-30 | -$2.63 | n/m | 2026-07-22, From 2025-05-01 |
| 2025-04-30 | -$11.32 | n/m | 2026-07-22, From 2024-05-01 |
| 2024-04-30 | -$132.33 | n/c | 2025-07-22, From 2023-05-01 |
| 2023-04-30 | -$22.89 | n/c | 2024-07-30, From 2022-05-01 |
| 2022-04-30 | -$0.14 | n/a | 2023-07-27, From 2021-05-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | 2026-04-30 | -$2.63 | n/m |
| Inhibitor Therapeutics, Inc. (INTI) | 2025-12-31 | -$0.02 | n/m |
| Accustem Sciences Inc. (ACUT) | 2025-12-31 | -$0.12 | n/m |
| Artelo Biosciences, Inc. (ARTL) | 2025-12-31 | -$12.52 | n/m |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | -$0.63 | n/m |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | -$3.20 | n/m |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | -$2.20 | n/m |
| InMed Pharmaceuticals Inc. (INM) | 2026-06-30 | -$3.12 | n/m |
| Hepion Pharmaceuticals, Inc. (HEPA) | 2025-12-31 | -$0.88 | n/m |
Compare ALZN, INTI, ACUT, ARTL side by side · Screen every company in Pharmaceutical Preparations ↗